By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Over 12 months, Abbott Laboratories saw more selling than buying from its insiders — purchases of about $4.4 million against sales of $47.5 million.
Biggest single buyer: Ford Robert B, CEO, with roughly $2 million. That includes C-suite money, which tends to get the most attention.
Looking at the quarterly pattern: Last full quarter: net selling by insiders. Insiders bought in 2 of the last 7 full quarters. Members of Congress reported 49 trades in ABT over the past two years (19 members). 2,964 investment managers listed ABT in their latest 13F filings (Q2 2026); more funds sold than bought.
Are insiders buying or selling ABT stock?
In the last 12 months Abbott Laboratories insiders made open-market purchases worth about $4.4 million and sales worth about $47.5 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in ABT?
The most recent open-market insider trade in ABT was filed on 2026-09-03.
How many institutions own ABT?
2,964 investment managers reported holding ABT in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded ABT?
Yes. Members of Congress reported 49 trades in ABT over the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).